Numerous molecular alterations associated with the occurrence of the aggressive HT of CLL (known as Richter transformation) have been identified, namely, genetic lesions of TP53, CDKN2A, NOTCH1, and c-MYC, dysregulation of immune checkpoints, and hyperactivation of the B cell receptor pathway. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.